Fundz

Protego Biopharma reported raising $51 Million in an initial SEC Form D filing, from an offering of $51 Million

PRIVATEOct 28, 2021

Amount Raised

$51 Million

$51 Million sold, per SEC Form D (first sale Oct 28, 2021)

Round Type

Venture

San DiegoBiotechnology

Quick answer

Protego Biopharma raised $51 Million in a funding round, dated October 28, 2021. Protego Biopharma is based in San Diego, California, United States.

How much did Protego Biopharma raise?
Protego Biopharma raised $51 Million in a funding round on October 28, 2021.
What does Protego Biopharma do?
Protego Bio is a clinical-stage company focused on the discovery and development of first-in-class small-molecule therapeutics that aim to reprogram protein folding for the treatment of various diseases.
Where is Protego Biopharma based and how big is it?
Protego Biopharma is based in San Diego, California, United States. Fundz records about 26 employees.
Who are the decision-makers at Protego Biopharma?
Fundz holds 3 contacts at Protego Biopharma, including the Chief Science Officer. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Protego Biopharma that raised within 45 days of this round, from Fundz verified event records.

  • DMC Biotechnologies raised $34M on December 10, 2021.
  • Phylos raised an undisclosed amount on December 10, 2021.
  • Blink Science, Inc. raised $780K (Seed) on December 10, 2021.
  • SpineThera, Inc. raised $1.2M (Seed) on December 10, 2021.
  • ProtoKinetix raised $20K on December 10, 2021.
  • Bolt Navigation raised $2.3M (Seed) on December 10, 2021.

Who to call at Protego Biopharma, and when

A new round usually means Protego Biopharma is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Protego Biopharma raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Protego Biopharma, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Protego Biopharma. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Protego Biopharma

Location

San Diego, California, United States

About

Protego Bio is a clinical-stage company focused on the discovery and development of first-in-class small-molecule therapeutics that aim to reprogram protein folding for the treatment of various diseases. We are exploring monogenetic protein misfolding diseases that cause myopathy, cardiomyopathy, stroke, renal disease, retinal diseases, channelopathies, and various degenerative diseases. Our approach builds on the proven pharmacological chaperone strategy exemplified by tafamidis, which was discovered and developed by our cofounders, Dr. Jeffery W. Kelly and Dr. Richard Labaudinière, for the treatment of transthyretin amyloidosis.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Protego Biopharma raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

3 contacts
Verified contactsMike P., Chief Science Officer hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Protego Biopharma's next move

See what Strategic adds

Protego Biopharma raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.